A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Clinical trial NCT05689151 · RECRUITING
Trial details
- NCT number
- NCT05689151
- Sponsor
- Pfizer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-09
- Primary completion
- 2027-12-31
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.